Black, Sarah
Phillips, Darci http://orcid.org/0000-0002-0804-3342
Hickey, John W.
Kennedy-Darling, Julia
Venkataraaman, Vishal G.
Samusik, Nikolay
Goltsev, Yury
Schürch, Christian M. http://orcid.org/0000-0002-1792-1768
Nolan, Garry P. http://orcid.org/0000-0002-8862-9043
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (5P01HL10879707)
U.S. Department of Health & Human Services | National Institutes of Health (5R01GM10983604, 5R33CA18365403, 5U01AI101984-07, 5UH2AR06767604, 5R01CA19665703, 5U54CA20997103, 5F99CA212231-02, 1F32CA233203-01, 5U01AI140498-02, 1U54HG010426-01, 5U19AI100627-07, 1R01HL120724-01A1, R33CA183692, R01HL128173-04, 5P01AI131374-02, 5UG3DK114937-02, 1U19AI135976-01, IDIQ17X149, 1U2CCA233238-01, 1U2CCA233195-01, AR007422, CA233203, T32CA196585)
U.S. Department of Defense (W81XWH-14-1-0180, W81XWH-12-1-0591)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (HHSF223201610018C, DSTL/AGR/00980/01)
Cancer Research UK (C27165/A29073)
Bill and Melinda Gates Foundation (OPP1113682)
Silicon Valley Community Foundation (2017-175329, 2017-177799-5022)
Pfizer (123214)
Celgene (133826, 133826)
American Cancer Society (PF-20-032-01-CSM)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P300PB_171189, P400PM_183915)
Article History
Received: 28 July 2020
Accepted: 14 April 2021
First Online: 2 July 2021
Competing interests
: J.K.-D. is an employee of Akoya Biosciences, Inc. N.S. is an employee of Becton Dickinson, Inc. G.P.N. received research grants from Pfizer, Inc.; Vaxart, Inc.; Celgene, Inc.; and Juno Therapeutics, Inc. during the course of this work. N.S., Y.G. and G.P.N. are inventors on US patent 9909167, granted to Stanford University, that covers some aspects of the technology described in this paper. J.K.-D., N.S., Y.G. and G.P.N. have equity in and/or are scientific advisory board members of Akoya Biosciences, Inc. C.M.S. is a scientific advisor to Enable Medicine, Inc. The other authors declare no competing interests.